摘要: |
[目的]观察补肾解毒通络方对活动期类风湿关节炎(RA)患者临床疗效及血清中血管新生相关因子的影响。[方法]将78例活动期RA患者随机分为治疗组(n=38)和对照组(n=40)。治疗组予补肾解毒通络方联合甲氨蝶呤治疗,对照组予单药甲氨蝶呤治疗。记录治疗前后患者VAS评分、28处关节疾病活动度评分(DAS28)、中医证候疗效评估、C反应蛋白(CRP)、血沉(ESR)的变化,同时检测血清中VEGF、bFGF、TGF-β1的数值变化,并观察治疗过程中出现的不良反应。[结果]治疗6个月后,两组在中医症状评分、VAS、DAS28评分、CRP较治疗前均值均下降(P<0.05);治疗组患者血清VEGF、bFGF水平较治疗前降低(P<0.05),TGF-β1水平较治疗前升高(P<0.05);对照组患者仅血清VEGF、bFGF水平较治疗前降低(P<0.05)。两组相比,治疗组中医症状评分、VAS、DAS28评分、CRP均值低于对照组(P<0.05);治疗组患者血清VEGF、bFGF水平较对照组明显降低(P<0.05),而TGF-β1水平较对照组明显升高(P<0.05)。[结论]补肾解毒通络方能有效缓解活动期RA临床症状,同时可通过下调RA患者血清中VEGF、bFGF,并上调TGF-β1的表达水平从而抑制新生血管增生,表明该方临床疗效可,且在对RA血管翳的形成可能具有一定的抑制作用。 |
关键词: 补肾解毒通络方 类风湿关节炎 临床疗效 血管新生相关因子 |
DOI:10.11656/j.issn.1672-1519.2018.10.04 |
分类号:R593.22 |
基金项目:国家自然基金项目(青年基金)(81704010);浦东新区卫生和计划生育委员会卫生科技项目(PW2015D-7);上海市卫生和计划生育委员会科研课题(20164Y0048)。 |
|
Effect of Bushen Tongluo Jiedu decoction on the angiogenesis relative factors in the serum of patients with rheumatoid arthritis |
HE Yikun, YANG Guanghui, ZHENG Yueqi, WU Huihui, PAN Xin, XU Xiaofang, YAO Jinghui
|
Department of Rheumatism, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200021, China
|
Abstract: |
[Objective] To investigate the effects of combined Bushen Tongluo Jiedu decoction on the correlation angiogenic growth factors in the serum of patients with rheumatoid arthritis(RA).[Methods] The 78 patients with RA were randomly divided into the treatment group (n=38) with Bushen Tongluo Jiedu decoction and methotrexate, and the control group (n=40) with only methotrexate. The change of VAS score, DAS28, TCM syndrome effect eveluation, CRP and ESR were recorded, and the changes of VEGF, bFGF and TGF-β1 in two groups before and after three months were observed. Untoward reaction during treatment was observed.[Results] After 6 months treatment, the scores of TCM symptoms, VAS, DAS28 and CRP in the two groups were decreased than before treatment(P<0.05). The treatment group to reduce the index levels of VEGF, bFGF in the serum was better than before treatment (P<0.05), and to raise the index levels of TGF-β1 was better than before treatment (P<0.05). The control group only vEGF and bEGF were better than before treatment (P<0.05). The scores of TCM symptoms, VAS, DAS28 and CRP in the treatment group were lower than those of the control group (P<0.05). VEGF and bFGF were remarkably decreased compared to that of control group (P<0.05), and TGF-β1 were significantly higher compared to that of control group (P<0.05).[Conclusion] The Bushen Tongluo Jiedu decoction can effectively relieve the clinical symptoms of RA in active stage, and the decoction through down-regulation of VEGF and bFGF, and up-regulation of TGF-β1 expression levels to inhibite angiogenic growth, it showed that it may have the inhibitory effect in the pannus formation of RA. |
Key words: Bushen Tongluo Jiedu decoction rheumatoid arthritis clinical efficacy angiogenesis relative factors |